GLP-1 analogues treatment was not associated with additional weight loss over intensive lifestyle intervention in severely obese patients with type 2 diabetes. (1st April 2015) - Tahrani, A.; Wright, A.; Kempegowda, P.; Abernethy, G.; Sadiqi, H.; Phillips, C.; McLease, J.; Golics, R.; Maxwell, E.; John, R.; Shakher, J.; Bellary, S.